Marjolein Metselaar-Albers

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

Chronic Myeloid Leukemia

Mesenchymal Stem Cells

Top Venues

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Marjolein Metselaar-Albers, Irma Meijerman, Ferdi Engels, John B A G Haanen, Jos Beijnen, Arief Lalmohamed
No detrimental association between antibiotic use and immune checkpoint inhibitor therapy: an observational cohort study comparing patients with ICI-treated and TKI-treated melanoma and NSCLC. Journal for immunotherapy of cancer 12 (1) (2024)
Marjolein Metselaar-Albers, Irma Meijerman, Ferdi Engels, John B A G Haanen, Jos Beijnen, Arief Lalmohamed
No detrimental association between antibiotic use and immune checkpoint inhibitor therapy: an observational cohort study comparing patients with ICI-treated and TKI-treated melanoma and NSCLC. Journal for immunotherapy of cancer 12 (1) (2024)
Marjolein Metselaar-Albers, Irma Meijerman, Ferdi Engels, John B A G Haanen, Jos Beijnen, Arief Lalmohamed
No detrimental association between antibiotic use and immune checkpoint inhibitor therapy: an observational cohort study comparing patients with ICI-treated and TKI-treated melanoma and NSCLC. Journal for immunotherapy of cancer 12 (1) (2024)
Marjolein Metselaar-Albers, Irma Meijerman, Ferdi Engels, John B A G Haanen, Jos Beijnen, Arief Lalmohamed
No detrimental association between antibiotic use and immune checkpoint inhibitor therapy: an observational cohort study comparing patients with ICI-treated and TKI-treated melanoma and NSCLC. Journal for immunotherapy of cancer 12 (1) (2024)